Literature DB >> 12044965

The 'intestinal-renal' arginine biosynthetic axis in the aging rat.

Sanjay K Mistry1, Ziv Greenfeld, Sidney M Morris, Chris Baylis.   

Abstract

It has been suggested that L-arginine availability declines with advanced age, which could contribute to the endothelial dysfunction and decreased nitric oxide (NO) production that are features of aging. L-Arginine is made in the kidney and since the aging kidney develops progressive injury there may be decreased synthesis limiting availability. In this study we investigated the impact of aging on the regulation, at the gene level, of the various enzymes that synthesize L-arginine in the kidney (argininosuccinate synthetase and argininosuccinate lyase) and citrulline, the precursor of L-arginine made in the small intestine (phosphate-dependent glutaminase, carbamyl phosphate synthetase-1 and ornithine transcarbamylase). Studies were in young (3-5 months), middle-aged (11-13 months) and old (18-22 months) male and female Sprague-Dawley rats aged under barrier conditions. The plasma, renal cortical and brain cerebellar levels of L-arginine are unchanged in the old male rat, and expression of the genes involved in renal arginine synthesis and small intestinal citrulline synthesis is unchanged or upregulated with age in both males and females. This study shows that the synthesis of L-arginine is maintained with aging despite developing kidney damage. Therefore, the reduced NO generating capacity that occurs in aging must be due to downstream changes in the NO biosynthesis pathway, such as reduced abundance of NO biosynthetic enzymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044965      PMCID: PMC2745251          DOI: 10.1016/s0047-6374(02)00003-9

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  26 in total

1.  Intestinal transfer of l-arginine in relation to age.

Authors:  L Pénzes
Journal:  Exp Gerontol       Date:  1970-09       Impact factor: 4.032

Review 2.  Arginine: biochemistry, physiology, and therapeutic implications.

Authors:  A Barbul
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Mar-Apr       Impact factor: 4.016

3.  Molecular cloning of cDNA for rat and human carbamyl phosphate synthetase I.

Authors:  M W Adcock; W E O'Brien
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

4.  Studies on the methylation of avian sarcoma proviruses in permissive and non-permissive cells.

Authors:  R A Katz; S A Mitsialis; R V Guntaka
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

5.  Source and fate of circulating citrulline.

Authors:  H G Windmueller; A E Spaeth
Journal:  Am J Physiol       Date:  1981-12

6.  Effect of aging on free amino acids and electrolytes in leg skeletal muscle.

Authors:  P Möller; J Bergström; S Eriksson; P Fürst; K Hellström
Journal:  Clin Sci (Lond)       Date:  1979-05       Impact factor: 6.124

7.  Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids.

Authors:  S M Morris; C L Moncman; K D Rand; G J Dizikes; S D Cederbaum; W E O'Brien
Journal:  Arch Biochem Biophys       Date:  1987-07       Impact factor: 4.013

8.  Indices of activity of the nitric oxide system in hemodialysis patients.

Authors:  R J Schmidt; J Domico; L S Samsell; S Yokota; T S Tracy; M I Sorkin; K Engels; C Baylis
Journal:  Am J Kidney Dis       Date:  1999-08       Impact factor: 8.860

9.  Molecular cloning of cDNA for rat argininosuccinate lyase and its expression in rat hepatoma cell lines.

Authors:  M A Lambert; L R Simard; P N Ray; R R McInnes
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 10.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

View more
  9 in total

1.  Rumen-protected arginine in ewe lambs: effects on circulating serum amino acids and carotid artery hemodynamics.

Authors:  Jena L Peine; Tammi L Neville; Erin E Klinkner; Kelsey E Egeland; Pawel P Borowicz; Allison M Meyer; Lawrence P Reynolds; Joel S Caton
Journal:  J Anim Sci       Date:  2020-07-01       Impact factor: 3.159

Review 2.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 3.  Sexual dimorphism in the aging kidney: differences in the nitric oxide system.

Authors:  Chris Baylis
Journal:  Nat Rev Nephrol       Date:  2009-06-02       Impact factor: 28.314

Review 4.  Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.

Authors:  Chris Baylis
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-07       Impact factor: 6.053

Review 5.  Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system.

Authors:  Chris Baylis
Journal:  Exp Gerontol       Date:  2005-04       Impact factor: 4.032

6.  Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase.

Authors:  Natasha C Moningka; Jennifer M Sasser; Byron Croker; Christy Carter; Chris Baylis
Journal:  Mech Ageing Dev       Date:  2010-11-16       Impact factor: 5.432

7.  Intestinal and hepatic metabolism of glutamine and citrulline in humans.

Authors:  Marcel C G van de Poll; Gerdien C Ligthart-Melis; Petra G Boelens; Nicolaas E P Deutz; Paul A M van Leeuwen; Cornelis H C Dejong
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

8.  Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats.

Authors:  Erkan Cure; Medine Cumhur Cure; Levent Tumkaya; Yildiray Kalkan; Ibrahim Aydin; Aynur Kirbas; Arif Yilmaz; Suleyman Yuce; Ahmet Fikret Yücel
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

Review 9.  Age-Related Neurochemical Changes in the Vestibular Nuclei.

Authors:  Paul F Smith
Journal:  Front Neurol       Date:  2016-03-03       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.